Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2670380332;80333;80334 chr2:178566025;178566024;178566023chr2:179430752;179430751;179430750
N2AB2506275409;75410;75411 chr2:178566025;178566024;178566023chr2:179430752;179430751;179430750
N2A2413572628;72629;72630 chr2:178566025;178566024;178566023chr2:179430752;179430751;179430750
N2B1763853137;53138;53139 chr2:178566025;178566024;178566023chr2:179430752;179430751;179430750
Novex-11776353512;53513;53514 chr2:178566025;178566024;178566023chr2:179430752;179430751;179430750
Novex-21783053713;53714;53715 chr2:178566025;178566024;178566023chr2:179430752;179430751;179430750
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTA
  • RefSeq wild type template codon: CAT
  • Domain: Fn3-82
  • Domain position: 21
  • Structural Position: 23
  • Q(SASA): 0.1926
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/L rs1288435749 0.075 0.015 N 0.337 0.065 0.274366138417 gnomAD-2.1.1 4.03E-06 None None None None N None 0 2.9E-05 None 0 0 None 0 None 0 0 0
V/L rs1288435749 0.075 0.015 N 0.337 0.065 0.274366138417 gnomAD-4.0.0 4.77584E-06 None None None None N None 0 6.86153E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.1029 likely_benign 0.091 benign -1.519 Destabilizing None N 0.177 neutral N 0.37365974 None None N
V/C 0.4008 ambiguous 0.391 ambiguous -0.808 Destabilizing 0.667 D 0.511 neutral None None None None N
V/D 0.3415 ambiguous 0.2901 benign -2.115 Highly Destabilizing 0.124 N 0.459 neutral None None None None N
V/E 0.2738 likely_benign 0.2396 benign -1.897 Destabilizing 0.175 N 0.463 neutral N 0.396149811 None None N
V/F 0.1109 likely_benign 0.1041 benign -0.899 Destabilizing 0.497 N 0.526 neutral None None None None N
V/G 0.1658 likely_benign 0.1458 benign -2.026 Highly Destabilizing 0.042 N 0.405 neutral N 0.425627356 None None N
V/H 0.3346 likely_benign 0.3029 benign -2.018 Highly Destabilizing 0.667 D 0.561 neutral None None None None N
V/I 0.0643 likely_benign 0.0644 benign -0.116 Destabilizing 0.001 N 0.214 neutral N 0.4190481 None None N
V/K 0.4072 ambiguous 0.3581 ambiguous -1.155 Destabilizing 0.22 N 0.455 neutral None None None None N
V/L 0.1005 likely_benign 0.0941 benign -0.116 Destabilizing 0.015 N 0.337 neutral N 0.388551835 None None N
V/M 0.0874 likely_benign 0.0838 benign -0.117 Destabilizing 0.497 N 0.485 neutral None None None None N
V/N 0.1383 likely_benign 0.1273 benign -1.488 Destabilizing 0.004 N 0.483 neutral None None None None N
V/P 0.9083 likely_pathogenic 0.884 pathogenic -0.557 Destabilizing 0.667 D 0.582 neutral None None None None N
V/Q 0.2271 likely_benign 0.2065 benign -1.295 Destabilizing 0.667 D 0.577 neutral None None None None N
V/R 0.3687 ambiguous 0.3096 benign -1.134 Destabilizing 0.497 N 0.588 neutral None None None None N
V/S 0.0843 likely_benign 0.075 benign -2.019 Highly Destabilizing 0.004 N 0.429 neutral None None None None N
V/T 0.0813 likely_benign 0.0798 benign -1.67 Destabilizing None N 0.167 neutral None None None None N
V/W 0.6483 likely_pathogenic 0.6242 pathogenic -1.528 Destabilizing 0.958 D 0.615 neutral None None None None N
V/Y 0.3324 likely_benign 0.3081 benign -1.033 Destabilizing 0.667 D 0.507 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.